These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8366716)

  • 21. False incoagulable PT-INR results in oral anticoagulant therapy.
    Redaelli R; Corno AR; Somaini MG; Gechtman C; Caimi TM; Baudo F; Morra E
    Thromb Res; 2008; 122(1):137-9. PubMed ID: 17996923
    [No Abstract]   [Full Text] [Related]  

  • 22. [Peroral anticoagulant therapy--are the TT-values reliable?].
    Eilertsen H; Asprang AF; Ulveland K; Nerdrum HJ
    Tidsskr Nor Laegeforen; 1998 Apr; 118(11):1690-2. PubMed ID: 9621756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.
    Mattsson C; Menschiek-Lundin A; Wåhlander K; Lindahl TL
    Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral anticoagulant therapy: quality-of-life issues.
    Beyth RJ
    Semin Vasc Med; 2003 Aug; 3(3):239-42. PubMed ID: 15199456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
    Crowther MA
    Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recommendations of the ICSH/ICTH for expressing prothrombin time in the control of the temperature with oral anticoagulants].
    Sangre (Barc); 1984; 29(6):1057-8. PubMed ID: 6533839
    [No Abstract]   [Full Text] [Related]  

  • 27. [A retrospective survey on practice of oral anticoagulant therapy in patients with cardiovascular diseases].
    Katona A; Márk L
    Orv Hetil; 2004 Aug; 145(32):1643-7. PubMed ID: 15384862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prothrombin time and Thrombotest in anticoagulant treatment].
    Loeliger EA; Hemker HC
    Ned Tijdschr Geneeskd; 1968 Nov; 112(48):2195-8. PubMed ID: 5704623
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of the quality of prothrombin time technique in the Basque Country].
    Vacas M; Lafuente PJ; Aguirrebeitia MJ; Iriarte JA
    Sangre (Barc); 1998 Feb; 43(1):41-5. PubMed ID: 9577180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy.
    Anderson DR; Harrison L; Hirsh J
    Arch Intern Med; 1993 Jun; 153(12):1441-7. PubMed ID: 8512435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK).
    Cosmi B; Palareti G; Carpanedo M; Pengo V; Biasiolo A; Rampazzo P; Morstabilini G; Testa S
    Haematologica; 2000 Aug; 85(8):826-31. PubMed ID: 10942929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral anticoagulant therapy--50 years later.
    Ansell JE
    Arch Intern Med; 1993 Mar; 153(5):586-96. PubMed ID: 8439222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The factors that influence the consistency of international normalized ratio of prothrombin time].
    Su W; Ren FQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Apr; 23(2):196-8. PubMed ID: 12905903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing the efficacy and safety of oral anticoagulant therapy: high-quality dose management, anticoagulation clinics, and patient self-management.
    Ansell JE
    Semin Vasc Med; 2003 Aug; 3(3):261-70. PubMed ID: 15199459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality assessment in point-of-care coagulation testing.
    Kitchen DP; Kitchen S; Jennings I; Woods T; Walker I
    Semin Thromb Hemost; 2008 Oct; 34(7):647-53. PubMed ID: 19085765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of Quick/INR values of whole capillary blood (CoaguChek Plus) and venous citrate plasma in patients with and without oral anticoagulation].
    Burri S; Demarmels Biasiutti F; Lämmle B; Wuillemin WA
    Schweiz Med Wochenschr; 1998 Oct; 128(44):1723-9. PubMed ID: 9846345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
    Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
    Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient education and oral anticoagulant therapy.
    Barcellona D; Contu P; Marongiu F
    Haematologica; 2002 Oct; 87(10):1081-6. PubMed ID: 12368164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.